Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Solara Active Pharma Sciences Ltd (SOLA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
552.00 +18.80    +3.53%
- Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE624Z01016 
S/N:  SOLARA
  • Volume: 498,852
  • Bid/Ask: 552.00 / 552.30
  • Day's Range: 529.75 - 560.95
Solara Active Pharma 552.00 +18.80 +3.53%

Solara Active Pharma Sciences Ltd Company Profile

 
Get an in-depth profile of Solara Active Pharma Sciences Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

2254

Equity Type

ORD

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, loop diuretic, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, topical anti-infectives, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, nucleoside inhibitor, aprepitant, NSAIDs, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company also exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Contact Information

Address Admin Block 27 2nd Floor
Vandaloor Kelambakkam Road Keelakottaiyur Village, Melakottaiyur Chennai,600127
India
Phone 91 44 4344 6700
Fax 91 44 4740 6190

Top Executives

Name Age Since Title
Poorvank Purohit - 2023 MD, CEO & Director
Arun Kumar Pillai 63 2021 Founder & Non-Executive Director
Ankur Nand Thadani 40 2019 Non-Executive Director
Kausalya Santhanam 57 2018 Independent Director
Mohan Muthunarayanan - 2022 COO & Executive Director
Rajendra Kumar Srivastava 73 2023 Independent Director
Ramakrishnan Rajagopal - 2018 Independent Director
Kartheek Chintalapati Raju 37 2021 Non-Executive Non-Independent Director
Rajiv Vijay Nabar 63 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SOLA Comments

Write your thoughts about Solara Active Pharma Sciences Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
manne anjaiah
manne anjaiah Feb 09, 2022 11:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it is falling why plz respond shall I keep or sell .I have 69 shares with ,at rs 1400
Arthur sp
Arthur sp Feb 09, 2022 11:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dec 21 quarter Revenue down 75% 100 from 400 cr from last one , net loss 140 cr, worst hit Solara, keep long term view & hold, more downside possible in short term
bharat dhawan
bharat dhawan Feb 09, 2022 11:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
jab consolidate hone lge aur selling ruk jaye then average . you will soon recover your loss
AMAR JEET
AMAR JEET Oct 30, 2020 1:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
LONGER PLAYER
Somenath Dey
Somenath Dey Apr 04, 2019 10:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TP 550 BEFORE MARCH 2019 RESULT
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email